article The promise of induced pluripotent stem cells for liver disease, toxicology and drug discovery 9 April 2015 | By James Adjaye (Institute for Stem Cell Research and Regenerative Medicine), Nina Graffmann (Institute for Stem Cell Research and Regenerative Medicine), Peggy Matz (Institute for Stem Cell Research and Regenerative Medicine), Wasco Wruck (Institute for Stem Cell Research and Regenerative Medicine) We discuss the steps required for differentiating human pluripotent stem cells into hepatocyte-like cells, and how long this process takes and the quality control measures needed...